01-01-1970 12:00 AM | Source: Accord Fintech
Sun Pharma`s US-based unit recalls 50,680 vials of Testosterone Cypionate Injection
Sun Pharmaceutical Industries’ US-based unit is recalling 50,680 vials of Testosterone Cypionate Injection, used to treat low testosterone in adult males, in the American market. The company is recalling the affected lot due to 'water leakage' leading to deviation from current good manufacturing practices (cGMP). The company is also recalling 27 vials of the same medication due to cGMP deviations. The affected lot was produced at Sun Pharma's Halol (Gujarat) based manufacturing plant.
Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.
Latest News
Evening Roundup : A Daily Report on Bullion Energy &...
Market Wrap Up by Shrikant Chouhan, Head Equity Rese...
Gold Special Report: Akshaya Tritiya 2024 by Religar...
FIIs stood as net sellers in equities as per May 09 ...
Perspective On AMFI Data by Sanjay Agarwal, Senior D...
Post market comment by Mandar Bhojane, Research Anal...
Daily Market Analysis : The market resumed its corre...
Indian shares drop most in three months; L&T drags
VC firm Venturi Partners invests $27 mn in K12 Techn...
TCS CEO Krithivasan earned $3 million in first year ...